Nanophase Technologies Corporation (NANX)
OTCMKTS: NANX · Delayed Price · USD
0.976
+0.026 (2.74%)
Apr 18, 2024, 1:42 PM EDT - Market closed

Company Description

Nanophase Technologies Corporation, a science-driven company, develops, manufactures, and sells integrated family of nanomaterial technologies in the United States.

It engages in engineered materials, formulation development, and commercial manufacturing. The company produces engineered nanomaterial products comprising antimony, bismuth, cerium, iron, and zinc oxide for use in a various markets, including surface finishing,exterior coatings, personal care, plastics, scratch resistant coatings, and textiles.

It also provides skin care formulations with mineral-based UV protection under the under the Solésence brand; and advanced material products, including architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, medical diagnostics, and surface finishing technologies applications.

The company was incorporated in 1989 and is headquartered in Romeoville, Illinois.

Nanophase Technologies Corporation
Country Israel
Founded 1989
IPO Date Nov 26, 1997
Industry Specialty Chemicals
Sector Materials
Employees 79
CEO Jess A. Jankowski

Contact Details

Address:
1319 Marquette Drive
Romeoville, Illinois 60446
United States
Phone 6303231200
Website nanophase.com

Stock Details

Ticker Symbol NANX
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000883107
CUSIP Number 630079101
ISIN Number US6300791018
Employer ID 36-3687863
SIC Code 2844

Key Executives

Name Position
Jess A. Jankowski President, Chief Executive Officer, Chief Financial Officer, Secretary, Treasurer and Director
Kevin Cureton Chief Operating Officer

Latest SEC Filings

Date Type Title
Apr 11, 2024 8-K Current Report
Mar 28, 2024 10-K Annual Report
Mar 21, 2024 8-K Current Report
Mar 5, 2024 8-K Current Report
Mar 5, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Feb 12, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Dec 21, 2023 EFFECT Notice of Effectiveness
Dec 19, 2023 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Nov 21, 2023 S-1 General form for registration of securities under the Securities Act of 1933
Nov 16, 2023 SC 13D/A [Amend] General statement of acquisition of beneficial ownership